Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Synbio Tech Inc. operates as a biotechnology enterprise, primarily focusing on the development and production of probiotics and their various applications. The company also handles the marketing and distribution of several products in China, such as lactic acid bacteria (LAB) beverages, LAB powders formulated for human health, and specialized probiotic solutions for the agriculture, forestry, fishery, and animal husbandry sectors. Established on June 1, 2000, the firm maintains its principal office in Kaohsiung City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.